2924 Time to response (TTR) and early tumor shrinkage (ETS) in recurrent glioblastoma patients treated with bevacizumab: An exploratory analysis of the prospective randomized AVAREG (ML25739) phase II study. (September 2015) - Franceschi, E.; Finocchiaro, G.; Zagonel, V.; Reni, M.; Fabi, A.; Caserta, C.; Clavarezza, M.; Maiello, E.; Cartený, G.; Rosti, G.; Tosoni, A.; Paccapelo, A.; et al.